Canada - English - Health Canada

guerbet - iodine (ethiodized oil) - liquid - 380mg - iodine (ethiodized oil) 380mg - roentgenography

Canada - English - Health Canada

guerbet - patent blue sodium - solution - 50mg - patent blue sodium 50mg - other diagnostic agents

Canada - English - Health Canada

guerbet - ioxaglate sodium; ioxaglate meglumine - solution - 196mg; 393mg - ioxaglate sodium 196mg; ioxaglate meglumine 393mg - roentgenography

Canada - English - Health Canada

guerbet - ioxaglate sodium; ioxaglate meglumine - solution - 123mg; 246mg - ioxaglate sodium 123mg; ioxaglate meglumine 246mg - roentgenography

Canada - English - Health Canada

guerbet - gadoterate meglumine - solution - 376.9mg - gadoterate meglumine 376.9mg - other diagnostic agents

United States - English - NLM (National Library of Medicine)

guerbet llc - ioxilan (unii: a4yj7j11tg) (ioxilan - unii:a4yj7j11tg) - ioxilan 300 mg in 1 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).